Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1

  • Authors:
    • Tomonori Nakazato
    • Morihiko Sagawa
    • Masahiro Kizaki
  • View Affiliations

  • Published online on: January 27, 2014     https://doi.org/10.3892/ijo.2014.2280
  • Pages: 1131-1138
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Triptolide, a diterpenoid trioxide purified from the Chinese herb Tripterygium wilfordii Hook F, has been used as a natural medicine in China for hundreds of years. Several reports have demonstrated that triptolide inhibits the proliferation of cancer cells in vitro and reduces the growth of several types of tumors in vivo. To address the potential of triptolide as a novel therapeutic agent for patients with multiple myeloma, we investigated the effects of triptolide on the induction of apoptosis in human multiple myeloma cells in vitro. Triptolide rapidly induces apoptotic cell death in various myeloma cell lines. Triptolide-induced apoptosis in myeloma cells is associated with the loss of mitochondrial transmembrane potential (∆ψm), the release of cytochrome c and Smac/DIABLO from mitochondria into the cytosol, and the activation of caspase-3 and caspase-9. Furthermore, triptolide induces a rapid decline in the levels of Mcl-1 protein that correlates with caspase activation and induction of apoptosis. Inhibition of Mcl-1 synthesis by triptolide occurs at the level of mRNA transcription and is associated with an inhibition of phosphorylation of RNA polymerase II CTD. These results indicate that Mcl-1 is an important target for triptolide-induced apoptosis in myeloma cells that occurs via inhibition of Mcl-1 mRNA transcription coupled with rapid protein degradation through the ubiquitin-proteasome pathway.

References

1. 

Kyle RA and Rajkumar SV: Multiple myeloma. Blood. 111:2962–2972. 2008. View Article : Google Scholar : PubMed/NCBI

2. 

Palumbo A and Anderson K: Multiple myeloma. N Engl J Med. 364:1046–1060. 2011. View Article : Google Scholar

3. 

Boyd KD, Pawlyn C, Morgan GJ and Davies FE: Understanding the molecular biology of myeloma and its therapeutic implications. Expert Rev Hematol. 5:603–617. 2012. View Article : Google Scholar : PubMed/NCBI

4. 

Watanabe R, Tokuhira M and Kizaki M: Current approaches for the treatment of multiple myeloma. Int J Hematol. 97:333–344. 2013. View Article : Google Scholar : PubMed/NCBI

5. 

Kumar S, Lee JH, Morgan G, et al: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia. 26:149–157. 2012. View Article : Google Scholar : PubMed/NCBI

6. 

Gu WZ and Brandwein SR: Inhibition of type II collagen-induced arthritis in rats by triptolide. Int J Immunopharmacol. 20:389–400. 1998. View Article : Google Scholar : PubMed/NCBI

7. 

Cibere J, Deng Z, Lin Y, et al: A randomized double blind, placebo controlled trial of tropical Tripterygium wilfordii in rheumatoid arthiritis: reanalysis using logistic regression analysis. J Rheumatol. 30:465–467. 2003.PubMed/NCBI

8. 

Shamon LA, Pezzuto JM, Graves JM, et al: Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett. 112:113–117. 1997. View Article : Google Scholar : PubMed/NCBI

9. 

Yang S, Chen J, Guo Z, et al: Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther. 2:65–72. 2003.PubMed/NCBI

10. 

Kiviharju TM, Lecane PS, Sellers RG and Peehl DM: Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res. 8:2666–2674. 2002.

11. 

Owa C, Messina ME Jr and Halaby R: Triptolide induces lysosomal-mediated programmed cell death in MCF-7 breast cancer cells. Int J Women’s Health. 5:557–569. 2013.PubMed/NCBI

12. 

Carter BZ, Mak DH, Schober WD, et al: Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells. Blood. 108:630–637. 2006. View Article : Google Scholar : PubMed/NCBI

13. 

Zhang C, Cui GH, Liu F, Wu QL and Chen Y: Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro. Acta Phramacol Sin. 27:1438–1446. 2006. View Article : Google Scholar : PubMed/NCBI

14. 

Carter BZ, Mak DH, Schober WD, et al: Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5. Blood. 111:3742–3750. 2008. View Article : Google Scholar : PubMed/NCBI

15. 

Fuchs O: Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematological malignancies. Curr Mol Pharmacol. 3:98–122. 2010.

16. 

Yang M, Huang J, Pan HZ and Jin J: Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-κB pathways in human multiple myeloma cells. Int J Mol Med. 22:489–496. 2008.PubMed/NCBI

17. 

YinJun L, Jie J and YunGui W: Triptolide inhibits transcription factor NF-κB and induces apoptosis of multiple myeloma cells. Leuk Res. 29:99–105. 2005.

18. 

Jiang XH, Wong BCY, Lin MCM, et al: Functional p53 is required for triptolide-induced apoptosis and AP-1 and NF-κB activation in gastric cancer cells. Oncogene. 20:8009–8018. 2001.PubMed/NCBI

19. 

Lin J, Chen LY, Lin ZX and Zhao ML: The effects of triptolide on apoptosis of glioblastoma multiforme (GBM) cells. J Int Med Res. 35:637–643. 2007. View Article : Google Scholar : PubMed/NCBI

20. 

Zhou GX, Ding XL, Zhang H, et al: Apoptosis of human pancreatic cells induced by triptolide. World J Gastroenterol. 14:1504–1509. 2008. View Article : Google Scholar : PubMed/NCBI

21. 

Lou YJ and Jin J: Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. Leuk Lymphoma. 45:373–376. 2004. View Article : Google Scholar : PubMed/NCBI

22. 

Shi Y, Jin Y, Cheng H, et al: Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Clin Cancer Res. 15:1686–1697. 2009. View Article : Google Scholar : PubMed/NCBI

23. 

Huang M, Zhang H, Jiu T, Tian D, Gu L and Zhou M: Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway. Mol Cancer Ther. 12:184–194. 2013. View Article : Google Scholar : PubMed/NCBI

24. 

Yang M, Shen JK, Huang J, Du HP, Ma QL and Jin J: Interleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma. Leuk Lymphoma. 50:802–808. 2009. View Article : Google Scholar : PubMed/NCBI

25. 

Jourdan M, Veyune JL, De Vos J, Redal N, Couderc G and Klein B: A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells. Oncogene. 22:2950–2959. 2003. View Article : Google Scholar : PubMed/NCBI

26. 

Le Gouill S, Podar K, Harousseau JL and Anderson KC: Mcl-1 regulation and its role in multiple myeloma. Cell Cycle. 3:1259–62. 2004.PubMed/NCBI

27. 

Le Gouill S, Podar K, Amiot M, et al: VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis. Blood. 104:2886–2892. 2004.PubMed/NCBI

28. 

Gomez-Bougie P, Wuillème-Toumi S, Ménoret E, et al: Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma. Cancer Res. 67:5418–5424. 2007. View Article : Google Scholar : PubMed/NCBI

29. 

Fan F, Tonon G, Bashari MH, et al: Targeting Mcl-1 for multiple myeloma (MM) therapy: drug-induced generation of Mcl-1 fragment Mcl-1128-350 triggers MM cell death via c-Jun upregulation. Cancer Lett. 28–Oct;2013.Epub ahead of print.

30. 

Leuenroth SJ and Crews CM: Triptolide-induced transcriptional arrest is associated with changes in nuclear substructure. Cancer Res. 68:5257–5266. 2008. View Article : Google Scholar : PubMed/NCBI

31. 

Vispe S, DeVries L, Creancier L, et al: Triptolide is an inhibitor of RNA polymerase I and II-dependent transcription leading predominantly to down-regulation of short-lived mRNA. Mol Cancer Ther. 8:2780–2790. 2009. View Article : Google Scholar : PubMed/NCBI

32. 

Wan CK, Wang C, Cheung HY, Yang M and Fong WF: Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-dependent HL-60 cells. Cancer Lett. 241:31–41. 2006. View Article : Google Scholar : PubMed/NCBI

33. 

Pan J: RNA polymerase an important molecular target of triptolide in cancer cells. Cancer Lett. 292:149–152. 2010. View Article : Google Scholar : PubMed/NCBI

34. 

Cai J and Jones DP: Mitochondrial redox signaling during apoptosis. J Bioenerg Biomemb. 31:327–334. 1999. View Article : Google Scholar

35. 

Chauhan D, Hideshima T and Anderson KC: Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma cells. J Biol Chem. 276:24453–24456. 2001.PubMed/NCBI

36. 

Chauhan D, Li G, Hideshima T and Anderson KC: JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma cells. J Biol Chem. 278:17593–17596. 2003. View Article : Google Scholar : PubMed/NCBI

37. 

Chauhan D, Li G, Hideshima T and Anderson KC: 2-methoxyestradiol overcomes drug resistance in multiple myeloma cells. Blood. 100:2187–2194. 2002. View Article : Google Scholar : PubMed/NCBI

38. 

Simon HU, Haj-Heyia A and Levi-Schaffer F: Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 5:415–418. 2000. View Article : Google Scholar : PubMed/NCBI

39. 

Hsu MJ, Sheu JR, Lin CH, Shen MY and Hsu CY: Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration. Biochim Biophys Acta. 1800:290–296. 2010. View Article : Google Scholar : PubMed/NCBI

40. 

Monteiro JP, Oliveira PJ and Jurado AS: Mitochondrial membrane lipid remodeling in pathophysiology: A new target for diet and therapeutic interventions. Prog Lipid Res. 52:513–528. 2013. View Article : Google Scholar : PubMed/NCBI

41. 

Mann J: Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer. 2:143–148. 2002. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2014
Volume 44 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Nakazato, T., Sagawa, M., & Kizaki, M. (2014). Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1. International Journal of Oncology, 44, 1131-1138. https://doi.org/10.3892/ijo.2014.2280
MLA
Nakazato, T., Sagawa, M., Kizaki, M."Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1". International Journal of Oncology 44.4 (2014): 1131-1138.
Chicago
Nakazato, T., Sagawa, M., Kizaki, M."Triptolide induces apoptotic cell death of multiple myeloma cells via transcriptional repression of Mcl-1". International Journal of Oncology 44, no. 4 (2014): 1131-1138. https://doi.org/10.3892/ijo.2014.2280